![Diane Mellett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Diane Mellett
Direttore/Membro del Consiglio presso
CIRCIO HOLDING ASA
Profilo
Ms. Diane Mellett is an Independent Director at Circio Holding ASA. She is on the Board of Directors at Circio Holding ASA. Ms. Mellett was previously employed as a Chief Business Officer & General Counsel by Affitech A/S and a General Counsel by Cambridge Antibody Technology Ltd. She also served on the board at BioXpress Therapeutics SA.
Posizioni attive di Diane Mellett
| Società | Posizione | Inizio |
|---|---|---|
| CIRCIO HOLDING ASA | Direttore/Membro del Consiglio | 14/09/2015 |
Precedenti posizioni note di Diane Mellett
| Società | Posizione | Fine |
|---|---|---|
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology Engages in research and development of human monoclonal antibodies | Consigliere Generale | 30/06/2006 |
BioXpress Therapeutics SA
 BioXpress Therapeutics SA BiotechnologyHealth Technology Provides biosimilar biologic APIs for unmet need indications such as cancer, inflammation and autoimmunity | Direttore/Membro del Consiglio | - |
Affitech A/S
 Affitech A/S Pharmaceuticals: MajorHealth Technology Researches and develops human antibody therapeutics | Direttore/Membro del Consiglio | 27/05/2010 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
40
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology Engages in research and development of human monoclonal antibodies | Health Technology |
Affitech A/S
Affitech A/S Pharmaceuticals: MajorHealth Technology Researches and develops human antibody therapeutics | Health Technology |
Circio Holding ASA
 Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines | Health Technology |
BioXpress Therapeutics SA
BioXpress Therapeutics SA BiotechnologyHealth Technology Provides biosimilar biologic APIs for unmet need indications such as cancer, inflammation and autoimmunity | Health Technology |
